LCAT gene therapy (NIH)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameLCAT gene therapy (NIH)
Drug Alias Namelecithin cholesterol acyltransferase gene therapy (NIH)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionPhosphatidylcholine-sterol acyltransferase stimulants
TargetsPhosphatidylcholine-sterol acyltransferase
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of Health
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A